John Cavan
Chief Executive Officer presso HEPION PHARMACEUTICALS, INC.
Patrimonio netto: 1 860 $ in data 31/03/2024
Provenienza dei contatti di primo grado di John Cavan
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 | |
| Subsidiary | Pharmaceuticals: Major | 20 | |
AlgoRx Pharmaceuticals, Inc.
 AlgoRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ.
7
| Extinct | Pharmaceuticals: Major | 7 |
| Subsidiary | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a John Cavan tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Chemicals: Agricultural | Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| GILEAD SCIENCES, INC. | Biotechnology | Sales & Marketing Corporate Officer/Principal | |
| SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| REPLIGEN CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Chief Executive Officer | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | President Corporate Officer/Principal Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| OKYO PHARMA LIMITED | Biotechnology | Director/Board Member Chief Executive Officer | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Director/Board Member | |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Pharmaceuticals: Other | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin Graduate Degree Doctorate Degree | |
| Dartmouth College | College/University | Masters Business Admin Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| University of Medicine & Dentistry of New Jersey | College/University | Chairman Doctorate Degree | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree | |
| University of Alberta | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| New York University | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Tulsa | College/University | Graduate Degree Graduate Degree | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Mangalore University | College/University | Undergraduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | President Sales & Marketing | |
| Powderject Pharmaceuticals, Inc. | Corporate Officer/Principal Corporate Officer/Principal | ||
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Founder Chief Operating Officer Chairman | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| New York University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Canada | 4 |
| Regno Unito | 3 |
| India | 2 |
| Bermuda | 2 |
Settori
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 3 |
| Finance | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 338 |
| Corporate Officer/Principal | 139 |
| Independent Dir/Board Member | 106 |
| Chairman | 74 |
| Chief Executive Officer | 55 |
Contatti più connessi
| Insiders | |
|---|---|
| Michael Powell | 48 |
| Tamar Howson | 41 |
| Eric Rowinsky | 36 |
| Arnold Lewis Oronsky | 35 |
| Michèle Ollier | 33 |
| Sol Barer | 32 |
| Jason S. Fisherman | 30 |
| James Sapirstein | 26 |
| Marc Beer | 25 |
| Paul Thomas | 23 |
| Thomas H. Adams | 22 |
| Christine Pellizzari | 22 |
| David Arkowitz | 20 |
| Sandy Smith | 19 |
| Christopher McGuigan | 17 |
- Borsa valori
- Insiders
- John Cavan
- Connessioni Società
